Pharmacytimes: Condition Center: Cardiovascular Health http://www.pharmacytimes.com/resource-centers/cardiovascular-health/condition-rss Cardiovascular Health en-us Thu, 05 May 2016 10:39:03 UTC Thu, 05 May 2016 10:39:03 UTC Entresto Shows Benefit Even in Clinically Stable Heart Failure Patients http://www.pharmacytimes.com/resource-centers/heart-failure/entresto-shows-benefit-even-in-clinically-stable-heart-failure-patients Novartis’ sacubitril/valsartan (Entresto) is showing promise for heart failure patients with reduced ejection fraction, regardless of background therapy or clinical stability. Thu, 14 Apr 2016 11:00:00 UTC Early Follow-Up Care After Heart Attack Key to Medication Adherence http://www.pharmacytimes.com/news/early-follow-up-care-after-heart-attack-key-to-medication-adherence Patients receiving follow-up care more than 6 weeks after a heart attack are much less likely to stick to their medication regimen. Thu, 24 Mar 2016 02:30:00 UTC ACS Patient Nonadherence Factors Pharmacists Should Target http://www.pharmacytimes.com/resource-centers/ACS/acs-patient-nonadherence-factors-pharmacists-should-target Seven in 10 patients report some extent of nonadherence prior to a hospitalization caused by a cardiovascular event such as acute cardiac failure. Fri, 06 Nov 2015 05:00:00 UTC What Hinders Good Heart Health Among African-Americans? http://www.pharmacytimes.com/news/what-hinders-good-heart-health-among-african-americans Cardiovascular disease (CVD) is the most common cause of death in America, but the disease rates for African-Americans are especially high. Mon, 12 Oct 2015 02:00:00 UTC Does DAPT Work as Well for Stroke as It Does for ACS? http://www.pharmacytimes.com/resource-centers/ACS/does-dapt-work-as-well-for-stroke-as-it-does-for-acs Dual antiplatelet therapy (DAPT) with aspirin and another antiplatelet agent such as clopidogrel, prasugrel, or ticagrelor is the go-to preventive therapy for patients who have experienced certain cardiovascular events. Sat, 03 Oct 2015 12:00:00 UTC Time to SPRINT to Lower Blood Pressure Target? http://www.pharmacytimes.com/news/time-to-sprint-to-lower-blood-pressure-target A target systolic blood pressure (SBP) of 120 mm Hg has outperformed the recommended 140 mm Hg target in the landmark SPRINT study. Mon, 14 Sep 2015 04:18:00 UTC Gout Means Greater Risk for Atrial Fibrillation http://www.pharmacytimes.com/resource-centers/afib/gout-means-greater-risk-for-atrial-fibrillation Gout patients may be at greater risk for atrial fibrillation. Wed, 09 Sep 2015 01:00:00 UTC Colchicine in Cardiovascular Disease: Old Drug, New Use http://www.pharmacytimes.com/resource-centers/ACS/colchicine-in-cardiovascular-disease-old-drug-new-use Colchicine (Colcrys) is a promising adjunctive option in secondary prevention of cardiovascular events, probably because of its ability to stop or slow neutrophil reaction to intravascular cholesterol crystals. Tue, 08 Sep 2015 01:48:00 UTC First-in-Class Heart Failure Drug Receives FDA Approval http://www.pharmacytimes.com/resource-centers/heart-failure/first-in-class-heart-failure-drug-receives-fda-approval The FDA today approved sacubitril/valsartan for treating heart failure. Tue, 07 Jul 2015 09:21:00 UTC Diabetes Drug Won't Worsen Heart Failure Risk http://www.pharmacytimes.com/resource-centers/diabetes/Diabetes-Drug-Wont-Worsen-Heart-Failure-Risk A study evaluating the cardiovascular safety of Merck's type 2 diabetes drug sitagliptin determined the dipeptidyl peptidase-4 inhibitor does not increase the risk for heart failure hospitalization. Sun, 14 Jun 2015 02:00:00 UTC In-Depth Analysis of Amgen Cholesterol Drug Favored by FDA Panel http://www.pharmacytimes.com/news/In-Depth-Analysis-of-Amgen-Cholesterol-Drug-Favored-by-FDA-Panel FDA officials have recommended approval for Amgen's proposed cholesterol-lowering medication, evolocumab (Repatha). Thu, 11 Jun 2015 05:17:00 UTC App Tracks Vitamin K Intake for Warfarin Patients http://www.pharmacytimes.com/resource-centers/vitamins-supplements/App-Tracks-Vitamin-K-Intake-for-Warfarin-Patients Pharmacists know changes in vitamin K intake can drastically alter INR values in patients taking warfarin. Thu, 11 Jun 2015 04:26:00 UTC Underprivileged African-Americans Have Higher Risk for Heart Disease http://www.pharmacytimes.com/news/Underprivileged-African-Americans-Have-Higher-Risk-for-Heart-Disease Recent research findings may help health care professionals participating in a new Affordable Care Act payment model identify patients at greatest risk for cardiovascular disease (CVD). Wed, 03 Jun 2015 01:00:00 UTC FDA Clears Medtronic Catheter for Atrial Fibrillation http://www.pharmacytimes.com/resource-centers/afib/FDA-Clears-Medtronic-Catheter-for-Atrial-Fibrillation The Arctic Front Advance ST Cryoablation Catheter is approved for use in patients with drug refractory, recurrent, symptomatic paroxysmal atrial fibrillation. Tue, 12 May 2015 06:12:00 UTC Can Vitamins Prevent Cardiovascular Calcification? http://www.pharmacytimes.com/resource-centers/vitamins-supplements/Can-Vitamins-Prevent-Cardiovascular-Calcification Since no medications or surgical procedures are available to treat cardiovascular calcification, clinicians generally recommend lifestyle changes. Sun, 10 May 2015 02:00:00 UTC Predicting Adverse Outcomes in Heart Failure Patients http://www.pharmacytimes.com/resource-centers/heart-failure/Predicting-Adverse-Outcomes-in-Heart-Failure-Patients A new prognostic model could help clinicians prioritize risk factors in heart failure patients. Sat, 09 May 2015 08:00:00 UTC Half of ACS Patients Don't Adhere to Antiplatelet Agents After Angioplasty http://www.pharmacytimes.com/resource-centers/ACS/Half-of-ACS-Patients-Dont-Adhere-to-Antiplatelet-Agents-After-Angioplasty Despite being told the importance of medication adherence, about half of acute coronary syndrome patients don't take their oral antiplatelet therapy as prescribed. Wed, 06 May 2015 02:34:00 UTC Brilinta Granted FDA Priority Review for New Use http://www.pharmacytimes.com/resource-centers/ACS/Brilinta-Granted-FDA-Priority-Review-for-New-Use The FDA has granted priority review to expand the use of AstraZeneca's ticagrelor (Brilinta). Tue, 05 May 2015 04:14:00 UTC Thiazide Diuretics Proven to Help Prevent Heart Failure http://www.pharmacytimes.com/resource-centers/heart-failure/Thiazide-Diuretics-Proven-to-Help-Prevent-Heart-Failure Thiazide diuretics are the least expensive antihypertensive drugs available in most countries. Sat, 02 May 2015 07:00:00 UTC New Guidelines Lower Blood Pressure Target for Coronary Artery Disease http://www.pharmacytimes.com/news/New-Guidelines-Lower-Blood-Pressure-Target-for-Coronary-Artery-Disease Here are the key points and rationale behind the lower blood pressure target. Thu, 30 Apr 2015 01:00:00 UTC